Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging.
PloS one
View this publicationPloS one
View this publicationClinical nutrition (Edinburgh, Scotland)
View this publicationThe Journal of allergy and clinical immunology
View this publicationJACC. Cardiovascular interventions
View this publicationNPJ systems biology and applications
View this publicationnpj aging
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationJournal of clinical medicine
View this publicationBMC ophthalmology
View this publicationCommunications biology
View this publication